New Studies Show Superior Distance Vision & Image Quality Performance of CooperVision MiSight® 1 day for Myopia Control

Two recently presented studies provide additional evidence to support why more than 175,000 age-appropriate children worldwide are successfully...

Read More

CooperVision Shares New Evidence-Based Research Projects, To Help Embrace Myopia Management

As part of its multifaceted leadership in helping more eye care professionals (ECPs) embrace myopia management, CooperVision is sharing insights...

Read More

WCO and CooperVision Advance Changing Approach to Myopia Management

The World Council of Optometry (WCO) and CooperVision, shared the results of a survey on the uptake of myopia management among global eye care...

Read More

CooperVision Expands MiSight 1 day to Cover Nearly 100% of Spherical Prescriptions for Children with Myopia

CooperVision announced that its MiSight® 1 day contact lenses will be available in higher prescriptions in June 2022 The expanded...

Read More

CooperVision Names Drs. Arumugam and Hammond to Expanded R&D Roles in Myopia Control and Management

CooperVision has announced expanded roles for two prominent researchers Baskar Arumugam, BOpt, PhD, FAAO, has been appointed Senior Lead Clinical...

Read More